There is 1 paper on metabolically active lipids in aging research: 1 trial in people.
1 paper studies it1 finding
See all 1 papers on metabolically active lipids
- Human trial1
Interventions
1Leucine + metformin + sildenafil
downin humans1
1 study
Leucine + metformin + sildenafil
downin humans1
Leucine + metformin + sildenafil decreases metabolically active lipids in humans (dose-responsive; overall and high ALT cohorts).
“with significant decreases in metabolically active lipids and up-regulation of fatty acid oxidation”
Human trialdose-responsive; overall and high ALT cohortstriple combination16 weeks
Alimentary pharmacology & therapeutics
Latest
Alimentary Pharmacology & Therapeutics
Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease
Randomized trial in 91 peopleLeucine